The DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.
A Method for the Acute and Rapid Degradation of Endogenous Proteins
Open accessAbstract
Methods for the targeted disruption of protein function have revolutionized science and greatly expedited the systematic characterization of genes. Two main approaches are currently used to disrupt protein function: DNA knockout and RNA interference, which act at the genome and mRNA level, respectively. A method that directly alters endogenous protein levels is currently not available. Here, we present Trim-Away, a technique to degrade endogenous proteins acutely in mammalian cells without prior modification of the genome or mRNA. Trim-Away harnesses the cellular protein degradation machinery to remove unmodified native proteins within minutes of application. This rapidity minimizes the risk that phenotypes are compensated and that secondary, non-specific defects accumulate over time. Because Trim-Away utilizes antibodies, it can be applied to a wide range of target proteins using off-the-shelf reagents. Trim-Away allows the study of protein function in diverse cell types, including non-dividing primary cells where genome- and RNA-targeting methods are limited.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The Trim-Away mechanism depletes target proteins directly at the protein level, bypassing limitations of transcriptional or RNA-targeting approaches and offering temporally precise control over protein levels.”
From Reverse the progression of Alzheimer’s disease through Nano-ERASER-based adult neuroregeneration (2026) · cites this paper as [21]
In the citing paper
“The longevity of TRIM-away efficacy was assessed to be roughly 3–4 days. However, this was dependent on the levels of target protein within cells, the amount of antibody being applied and the amount of TRIM21 within cells.”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [40]
In the citing paper
“The power of TRIM-away was also shown by its ability to target and degrade Rec8 in mouse oocytes within minutes [40].”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [40]
In the citing paper
“As shown by targeting huntingtin, TRIM-Away was also able to distinguish between wild-type and mutant proteins, depending on the specificity of the delivered antibody [40].”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [40]
In the citing paper
“The system could also be applied to primary cells, in which achieving protein silencing with RNAi or CRISPR/Cas9 is difficult.”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [40]
In the citing paper
“Using a GFP-specific antibody for microinjection into TRIM21 expressing cells, GFP levels were depleted with an apparent half-life of roughly 16 min [40].”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [40]
In the citing paper
“To widen the applicability of the system beyond single cell analysis, the authors developed a bulk cell approach by using electroporation, showing specific effects on signalling pathways like ERK1 or mTOR [40].”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Introduction to NF-κB: players, pathways, perspectives
Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209954 · Cited by 2,293
Laplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,284
Altering the Genome by Homologous Recombination
Capecchi, M. R. (1989) · Science · doi:10.1126/science.2660260 · Cited by 2,037
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,752
An auxin-based degron system for the rapid depletion of proteins in nonplant cells
Nishimura, K., Fukagawa, T., Takisawa, H., Kakimoto, T., & Kanemaki, M. (2009) · Nature Methods · doi:10.1038/nmeth.1401 · Cited by 1,663
Flagged first, then by citations
2 of the 65 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Lysosome-targeting chimaeras for degradation of extracellular proteins
Banik, S. M., Pedram, K., Wisnovsky, S., Ahn, G., Riley, N. M., & Bertozzi, C. R. (2020) · Nature · doi:10.1038/s41586-020-2545-9 · Cited by 1,199
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
Burslem, G. M., & Crews, C. M. (2020) · Cell · doi:10.1016/j.cell.2019.11.031 · Cited by 1,079
Targeted protein degradation: mechanisms, strategies and application
Zhao, L., Zhao, J., Zhong, K., Tong, A., & Jia, D. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00966-4 · Cited by 1,035
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Takahashi, D., Moriyama, J., Nakamura, T., Miki, E., Takahashi, E., Sato, A., Akaike, T., Itto-Nakama, K., & Arimoto, H. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.009 · Cited by 675
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
Ahn, G., Banik, S. M., Miller, C. L., Riley, N. M., Cochran, J. R., & Bertozzi, C. R. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00770-1 · Cited by 665
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Boland, B., Yu, W. H., Corti, O., Mollereau, B., Henriques, A., Bézard, E., Pastores, G., Rubinsztein, D. C., Nixon, R. A., Duchen, M. R., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.109 · Cited by 566
Cotton, A. D., Nguyen, D. P., Gramespacher, J. A., Seiple, I. B., & Wells, J. A. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c10008 · Cited by 551
Yesbolatova, A., Saito, Y., Kitamoto, N., Makino‐Itou, H., Ajima, R., Nakano, R., Nakaoka, H., Fukui, K., Gamo, K., Tominari, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19532-z · Cited by 544
HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation
Magupalli, V. G., Negro, R., Tian, Y., Hauenstein, A. V., Caprio, G. D., Skillern, W., Deng, Q., Ørning, P., Alam, H. B., Maliga, Z., et al. (2020) · Science · doi:10.1126/science.aas8995 · Cited by 392
Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
Nabet, B., Ferguson, F. M., Seong, B. K. A., Kuljanin, M., Leggett, A. L., Mohardt, M. L., Robichaud, A., Conway, A. S., Buckley, D. L., Mancias, J. D., et al. (2020) · doi:10.1101/2020.03.13.980946 · Cited by 312
Antibody targeting of E3 ubiquitin ligases for receptor degradation
Marei, H., Tsai, W.-T. K., Kee, Y.-S., Ruiz, K., He, J., Cox, C., Sun, T., Penikalapati, S., Dwivedi, P., Choi, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05235-6 · Cited by 273
Initiation of a conserved trophectoderm program in human, cow and mouse embryos
Gerri, C., McCarthy, A., Alanis‐Lobato, G., Demtschenko, A., Bruneau, A., Loubersac, S., Fogarty, N. M. E., Hampshire, D., Elder, K. T., Snell, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2759-x · Cited by 266
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Alabi, S. B., & Crews, C. M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100647 · Cited by 279
Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis
Castro-Dopico, T., Dennison, T. W., Ferdinand, J. R., Mathews, R. J., Fleming, A., Clift, D., Stewart, B. J., Jing, C., Strongili, K., Labzin, L. I., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.02.006 · Cited by 248
Self-citationBypassing Endocytosis: Direct Cytosolic Delivery of Proteins
Du, S., Liew, S. S., Li, L., & Yao, S. Q. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b06584 · Cited by 225
Targeted Intracellular Delivery of Antibodies: The State of the Art
Slastnikova, T. A., Ulasov, A. V., Rosenkranz, A. A., & Sobolev, A. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01208 · Cited by 214
Time-resolved protein activation by proximal decaging in living systems
Wang, J., Liu, Y., Liu, Y., Zheng, S., Wang, X., Zhao, J., Yang, F., Zhang, G., Wang, C., & Chen, P. R. (2019) · Nature · doi:10.1038/s41586-019-1188-1 · Cited by 203
Wu, Q., Qian, W., Sun, X., & Jiang, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01362-9 · Cited by 208
Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective
Luh, L. M., Scheib, U., Juenemann, K., Wortmann, L., Brands, M., & Cromm, P. M. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004310 · Cited by 201
Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown
Jin, Y., Lu, M., Wang, Y., Shan, W.-X., Wang, X.-Y., You, Q., & Jiang, Z. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02058 · Cited by 189
Targeted protein degradation as a powerful research tool in basic biology and drug target discovery
Wu, T., Yoon, H., Xiong, Y., Dixon-Clarke, S. E., Nowak, R. P., & Fischer, E. S. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0438-0 · Cited by 186
Chi, F., Sharpley, M. S., Nagaraj, R., Roy, S. S., & Banerjee, U. K. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.02.015 · Cited by 191
Harnessing the Power of Proteolysis for Targeted Protein Inactivation
Verma, R., Mohl, D., & Deshaies, R. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.010 · Cited by 185
Acute and rapid degradation of endogenous proteins by Trim-Away
Clift, D., So, C., McEwan, W. A., James, L. C., & Schuh, M. (2018) · Nature Protocols · doi:10.1038/s41596-018-0028-3 · Cited by 176
Self-citationMammalian oocytes store mRNAs in a mitochondria-associated membraneless compartment
Cheng, S., Altmeppen, G., So, C., Welp, L. M., Penir, S. M. U., Ruhwedel, T., Menelaou, K., Harasimov, K., Stützer, A., Blayney, M. L., et al. (2022) · Science · doi:10.1126/science.abq4835 · Cited by 173
Self-citationA liquid-like spindle domain promotes acentrosomal spindle assembly in mammalian oocytes
So, C., Seres, K. B., Steyer, A. M., Mönnich, E. U., Clift, D., Pejkovska, A., Möbius, W., & Schuh, M. (2019) · Science · doi:10.1126/science.aat9557 · Cited by 167
Self-citationTRIM family contribute to tumorigenesis, cancer development, and drug resistance
Huang, N., Sun, X., Li, P., Liu, X., Zhang, X., Chen, Q., & Xin, H. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00322-w · Cited by 169
Assembly and Positioning of the Oocyte Meiotic Spindle
Mogessie, B., Scheffler, K., & Schuh, M. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060553 · Cited by 167
Self-citationZygotic genome activation by the totipotency pioneer factor Nr5a2
Gassler, J., Kobayashi, W., Gáspár, I., Ruangroengkulrith, S., Mohanan, A., Hernández, L. G., Kravchenko, P., Kümmecke, M., Lalic, A., Rifel, N., et al. (2022) · Science · doi:10.1126/science.abn7478 · Cited by 154
G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD
Coyne, A. N., Zaepfel, B. L., Hayes, L., Fitchman, B., Salzberg, Y., Luo, E.-C., Bowen, K., Trost, H., Aigner, S., Rigo, F., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.027 · Cited by 156
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Qian, L., Lin, X., Gao, X., Khan, R. U., Liao, J.-Y., Du, S., Ge, J., Zeng, S., & Yao, S. Q. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00915 · Cited by 155
Molecular insights into cardiomyopathies associated with desmin (DES) mutations
Brodehl, A., Gärtner, A., & Milting, H. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0429-0 · Cited by 160
TRIM21—From Intracellular Immunity to Therapy
Foss, S., Bottermann, M., Jonsson, A., Sandlie, I., James, L. C., & Andersen, J. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02049 · Cited by 156
Self-citationMechanism of spindle pole organization and instability in human oocytes
So, C., Menelaou, K., Uraji, J., Harasimov, K., Steyer, A. M., Seres, K. B., Bucevičius, J., Lukinavičius, G., Möbius, W., Sibold, C., et al. (2022) · Science · doi:10.1126/science.abj3944 · Cited by 154
Self-citationTovell, H., Testa, A., Maniaci, C., Zhou, H., Prescott, A. R., Macartney, T., Ciulli, A., & Alessi, D. R. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b01016 · Cited by 146
Characterization of zygotic genome activation-dependent maternal mRNA clearance in mouse
Sha, Q., Zhu, Y., Li, S., Jiang, Y., Chen, L., Sun, X., Shen, L., Ou, X., & Fan, H. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1111 · Cited by 144
Coyne, A. N., Baskerville, V., Zaepfel, B. L., Dickson, D. W., Rigo, F., Bennett, F., Lusk, C. P., & Rothstein, J. D. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe1923 · Cited by 143
Intercellular Spread of Protein Aggregates in Neurodegenerative Disease
Davis, A. A., Leyns, C. E. G., & Holtzman, D. M. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062636 · Cited by 131
Ho, M., Kavanagh, E. L., Dunne, L., Dowling, P., Zhang, L., Lindsay, S., Bazou, D., Goh, C. Y., Hanley, C., Bianchi, G., et al. (2019) · Cancers · doi:10.3390/cancers11010066 · Cited by 132
The state of the art of PROTAC technologies for drug discovery
Wang, C., Zheng, C., Wang, H., Zhang, L., Liu, Z., & Xu, P. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114290 · Cited by 129
Post-translational modifications: Regulators of neurodegenerative proteinopathies
Gupta, R. V., Sahu, M., Srivastava, D., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101336 · Cited by 126
Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery
Pei, J., Wang, G., Feng, L., Zhang, J., Jiang, T., Sun, Q., & Ouyang, L. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01689 · Cited by 124
Revisiting the Roles of Pro-Metastatic EpCAM in Cancer
Mohtar, M. A., Syafruddin, S. E., Nasir, S., & Low, T. Y. (2020) · Biomolecules · doi:10.3390/biom10020255 · Cited by 124
Conditional control of fluorescent protein degradation by an auxin-dependent nanobody
Daniel, K., Icha, J., Horenburg, C., Müller, D., Norden, C., & Mansfeld, J. (2018) · Nature Communications · doi:10.1038/s41467-018-05855-5 · Cited by 113
Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities
Harding, R., & Tong, Y. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.11 · Cited by 114
Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders
Lu, P., Cheng, Y., Xue, L., Ren, X., Xu, X., Chen, C., Cao, L., Li, J., Wu, Q., Sun, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.10.015 · Cited by 119
Segregating Chromosomes in the Mammalian Oocyte
Mihajlović, A. I., & FitzHarris, G. (2018) · Current Biology · doi:10.1016/j.cub.2018.06.057 · Cited by 110
Target-induced clustering activates Trim-Away of pathogens and proteins
Zeng, J., Santos, A. F., Mukadam, A. S., Osswald, M., Jacques, D. A., Dickson, C. F., McLaughlin, S. H., Johnson, C. M., Kiss, L., Lupták, J., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00560-2 · Cited by 107
Self-citationEpigenetic Reprogramming in Early Animal DevelopmentPreprint
Du, Z., Zhang, K., & Xie, W. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a039677 · Cited by 105
Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins
Lin, J., Jin, J., Shen, Y., Zhang, L., Gong, G., Bian, H., Chen, H., Nagle, D. G., Wu, Y., Zhang, W., et al. (2021) · Theranostics · doi:10.7150/thno.62686 · Cited by 102
TFIID Enables RNA Polymerase II Promoter-Proximal Pausing
Fant, C. B., Levandowski, C. B., Gupta, K., Maas, Z. L., Moir, J. T., Rubin, J. D., Sawyer, A. J., Esbin, M. N., Rimel, J. K., Luyties, O., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.008 · Cited by 98
TRIM11 protects against tauopathies and is down-regulated in Alzheimer’s disease
Zhang, Z., Harischandra, D. S., Wang, R., Ghaisas, S., Zhao, J. Y., McMonagle, T. P., Zhu, G., Lacuarta, K. D., Song, J., Trojanowski, J. Q., et al. (2023) · Science · doi:10.1126/science.add6696 · Cited by 95
Kimberland, M. L., Hou, W., Alfonso-Pecchio, A. R., Wilson, S. P., Rao, Y., Zhang, S., & Lu, Q. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.08.007 · Cited by 99
Ahn, G., Banik, S. M., & Bertozzi, C. R. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.02.024 · Cited by 98
Dong, G., Wu, Y., Cheng, J., Chen, L., Liu, R., Ding, Y., Wu, S., Ma, J., & Sheng, C. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02001 · Cited by 96
Peroxiredoxins wear many hats: Factors that fashion their peroxide sensing personalities
Bolduc, J. A., Koruza, K., Luo, T., Pueyo, J. M., Vo, T. N., Ezeriņa, D., & Messens, J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101959 · Cited by 92
Protein degradation technology: a strategic paradigm shift in drug discovery
Li, H., Dong, J., Cai, M., Xu, Z., Cheng, X., & Qin, J. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01146-7 · Cited by 96
Advances in targeted degradation of endogenous proteins
Röth, S., Fulcher, L. J., & Sapkota, G. P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03112-6 · Cited by 92
Molecular Strategies to Target Protein Aggregation in Huntington’s Disease
Jarosińska, O. D., & Rüdiger, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.769184 · Cited by 92
Meiotic Kinetochores Fragment into Multiple Lobes upon Cohesin Loss in Aging Eggs
Zielinska, A. P., Bellou, E., Sharma, N., Frombach, A.-S., Seres, K. B., Gruhn, J. R., Blayney, M. L., Eckel, H., Moltrecht, R., Elder, K. T., et al. (2019) · Current Biology · doi:10.1016/j.cub.2019.09.006 · Cited by 81
Self-citationIntracellular Protein Delivery: Approaches, Challenges, and Clinical Applications
Chan, A., & Tsourkas, A. (2023) · BME Frontiers · doi:10.34133/bmef.0035 · Cited by 93
STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production
Li, D., Wu, R., Guo, W., Xie, L., Qiao, Z., Chen, S., Zhu, J., Huang, C., Huang, J. A., Chen, B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.069 · Cited by 87
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models
Mukadam, A. S., Miller, L. V. C., Smith, A. E., Vaysburd, M., Sakya, S. A., Sanford, S., Keeling, S., Tuck, B. J., Katsinelos, T., Green, C., et al. (2023) · Science · doi:10.1126/science.abn1366 · Cited by 84
Self-citationZhang, B., Brahma, R. K., Zhu, L., Feng, J., Hu, S., Qian, L., Du, S., Yao, S. Q., & Ge, J. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c08886 · Cited by 88
Deubiquitinating enzyme amino acid profiling reveals a class of ubiquitin esterases
Cesare, V. D., Carbajo, D., Mabbitt, P. D., Fletcher, A. J., Soetens, M., Antico, O., Wood, N. T., & Virdee, S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006947118 · Cited by 82
Mouse oocytes sequester aggregated proteins in degradative super-organelles
Zaffagnini, G., Cheng, S., Salzer, M. C., Pernaute, B., Duran, J. M., Irimia, M., Schuh, M., & Böke, E. (2024) · Cell · doi:10.1016/j.cell.2024.01.031 · Cited by 90
Self-citationTo TRIM or not to TRIM: the balance of host–virus interactions mediated by the ubiquitin system
Hage, A., & Rajsbaum, R. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001341 · Cited by 80
Biomimetic cell-derived nanocarriers in cancer research
Soprano, E., Polo, E., Pelaz, B., & del Pino, P. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01748-4 · Cited by 84
Maier, M., Welt, T., Wirth, F., Montrasio, F., Preisig, D. F., McAfoose, J., Vieira, F. G., Kulic, L., Späni, C. B., Stehle, T., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah3924 · Cited by 86
Intracellular neutralisation of rotavirus by VP6-specific IgG
Caddy, S., Vaysburd, M., Wing, M. G., Foss, S., Andersen, J. T., O‘Connell, K., Mayes, K., Higginson, K., Iturriza‐Gómara, M., Desselberger, U., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008732 · Cited by 81
Self-citationViral nucleoprotein antibodies activate TRIM21 and induce T cell immunity
Caddy, S., Vaysburd, M., Papa, G., Wing, M. G., O’Connell, K., Stoycheva, D., Foss, S., Andersen, J. T., Oxenius, A., & James, L. C. (2020) · The EMBO Journal · doi:10.15252/embj.2020106228 · Cited by 79
Self-citationZhang, K., Lu, X., Li, Y., Jiang, X., Liu, L., & Wang, H. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09620-6 · Cited by 78
Silicon‐Nanotube‐Mediated Intracellular Delivery Enables Ex Vivo Gene Editing
Chen, Y., Aslanoglou, S., Murayama, T., Gervinskas, G., FitzGerald, L. I., Sriram, S., Tian, J. M., Johnston, A. P. R., Morikawa, Y., Suu, K., et al. (2020) · Advanced Materials · doi:10.1002/adma.202000036 · Cited by 78
Complement C4 Prevents Viral Infection through Capsid Inactivation
Bottermann, M., Foss, S., Caddy, S., Clift, D., van Tienen, L. M., Vaysburd, M., Cruickshank, J., O’Connell, K., Clark, J., Mayes, K., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.02.016 · Cited by 75
Self-citationAntiviral PROTACs: Opportunity borne with challenge
Liang, J., Wu, Y., Lan, K., Dong, C., Wu, S., Li, S., & Zhou, H. (2023) · Cell Insight · doi:10.1016/j.cellin.2023.100092 · Cited by 76
Functions of actin in mouse oocytes at a glance
Uraji, J., Scheffler, K., & Schuh, M. (2018) · Journal of Cell Science · doi:10.1242/jcs.218099 · Cited by 74
Self-citationCytosolic delivery of inhibitory antibodies with cationic lipids
Wang, H. H., & Tsourkas, A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913973116 · Cited by 69
Opportunities and challenges of protein-based targeted protein degradation
Shen, F., & Dassama, L. M. K. (2023) · Chemical Science · doi:10.1039/d3sc02361c · Cited by 70
Amino acid homorepeats in proteins
Chavali, S., Singh, A. K., Santhanam, B., & Babu, M. M. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-0204-1 · Cited by 70
Chan, A., Haley, R. M., Najar, M. A., Gonzalez-Martinez, D., Bugaj, L. J., Burslem, G. M., Mitchell, M. J., & Tsourkas, A. (2024) · Nature Communications · doi:10.1038/s41467-024-50235-x · Cited by 72
PROTAC 2.0: Expanding the frontiers of targeted protein degradation
Cornu, M., Lemaitre, T., Kieffer, C., & Voisin‐Chiret, A. S. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104376 · Cited by 71
Two mechanisms drive pronuclear migration in mouse zygotes
Scheffler, K., Uraji, J., Jentoft, I. M. A., Cavazza, T., Mönnich, E. U., Mogessie, B., & Schuh, M. (2021) · Nature Communications · doi:10.1038/s41467-021-21020-x · Cited by 67
Self-citationTRIM21‐mediated proteasomal degradation of SAMHD1 regulates its antiviral activity
Li, Z., Huan, C., Wang, H., Liu, Y., Liu, X., Su, X., Yu, J., Zhao, Z., Yu, X., Zheng, B., et al. (2019) · EMBO Reports · doi:10.15252/embr.201847528 · Cited by 67
Recent advances in the development of EGFR degraders: PROTACs and LYTACs
Hong, D., Zhou, B., Zhang, B., Ren, H., Zhu, L., Zheng, G., Ge, M., & Ge, J. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114533 · Cited by 67
zGrad is a nanobody-based degron system that inactivates proteins in zebrafish
Yamaguchi, N., Colak-Champollion, T., & Knaut, H. (2019) · eLife · doi:10.7554/elife.43125 · Cited by 64
Antibody RING-Mediated Destruction of Endogenous Proteins
Ibrahim, A. F. M., Shen, L., Tatham, M. H., Dickerson, D. R., Prescott, A. R., Abidi, N., Xirodimas, D. P., & Hay, R. T. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.032 · Cited by 64
Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions
Chatterjee, P., Ponnapati, M., Kramme, C. C., Pleşa, A. M., Church, G. M., & Jacobson, J. M. (2020) · Communications Biology · doi:10.1038/s42003-020-01470-7 · Cited by 65
AKT kinases as therapeutic targets
Hassan, D., Menges, C. W., Testa, J. R., & Bellacosa, A. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03207-4 · Cited by 70
Alex, A., Piano, V., Polley, S., Stuiver, M., Voß, S., Ciossani, G., Overlack, K., Voß, B., Wohlgemuth, S., Petrović, A., et al. (2019) · eLife · doi:10.7554/elife.48287 · Cited by 63
Targeted Protein Degradation Tools: Overview and Future Perspectives
Prozzillo, Y., Fattorini, G., Santopietro, M. V., Suglia, L., Ruggiero, A., Ferreri, D., & Messina, G. (2020) · Biology · doi:10.3390/biology9120421 · Cited by 60
Siepe, D. H., Picton, L. K., & García, K. C. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00587 · Cited by 62
Optogenetic regulation of endogenous proteins
Redchuk, T. A., Karasev, M. M., Verkhusha, P. V., Donnelly, S. K., Hülsemann, M., Virtanen, J., Moore, H. M., Vartiainen, M. K., Hodgson, L., & Verkhusha, V. V. (2020) · Nature Communications · doi:10.1038/s41467-020-14460-4 · Cited by 59
Cell-Permeant Bioadaptors for Cytosolic Delivery of Native Antibodies: A “Mix-and-Go” Approach
Du, S., Liew, S. S., Zhang, C., Du, W., Lang, W., Yao, C. C. Y., Li, L., Ge, J., & Yao, S. Q. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c01379 · Cited by 57
Targeted protein degradation in drug development: Recent advances and future challenges
Song, J. H., Hu, M., Zhou, J., Xie, S., Li, T., & Li, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115839 · Cited by 56
Abuhashem, A., Lee, A. S., Joyner, A. L., & Hadjantonakis, A. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.03.013 · Cited by 56
A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation
Fletcher, A., Clift, D., de Vries, E., Cuesta, S. M., Malcolm, T., Meghini, F., Chaerkady, R., Wang, J., Chiang, A. J., Weng, S. H. S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42546-2 · Cited by 60
Self-citationKiss, L., Clift, D., Renner, N., Neuhaus, D., & James, L. C. (2021) · Nature Communications · doi:10.1038/s41467-021-21443-6 · Cited by 55
Self-citationCholesterol determines the cytosolic entry and seeded aggregation of tau
Tuck, B. J., Miller, L. V. C., Katsinelos, T., Smith, A. E., Wilson, E. L., Keeling, S., Cheng, S., Vaysburd, M. J., Knox, C., Tredgett, L., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110776 · Cited by 57
Self-citationA modular degron library for synthetic circuits in mammalian cells
Chassin, H., Müller, M., Tigges, M., Scheller, L., Lang, M., & Fussenegger, M. (2019) · Nature Communications · doi:10.1038/s41467-019-09974-5 · Cited by 57
Chan, E. K. L. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08911-z · Cited by 53
Metadata
- Authors
- Clift, D., McEwan, W. A., Labzin, L. I., Konieczny, V., Mogessie, B., James, L. C., & Schuh, M.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Max Planck Institute for Biophysical Chemistry (DE)
- Corresponding author
- Clift, Dean
- James, Leo C.
- Schuh, Melina
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 171
- Issue
- 7
- Pages
- 1692-1706.e18
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5733393
- OpenAlex
- W2769995426
- Cited by
- 531
- References
- 65
- Citations by year
- 2026: 65 · 2025: 85 · 2024: 59 · 2023: 72 · 2022: 52 · 2021: 62 · 2020: 58 · 2019: 45 · 2018: 30 · 2017: 2
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Cell (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion, cc-by)
- GRO (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Medical Research Council (MC_U105192711, MC_U105181010)
- European Community’s Seventh Framework Programme (241548)
- European Research Council (ERC (337415)
- Wellcome Trust Investigator Award (200594/Z/16/Z)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- mammalian cells, gene function analysis
- MeSH terms
- Animals, Antibodies, Biochemistry, Protein Transport, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
